NCT02479373

Brief Summary

This research is being done to see if resistance exercise (RE) is safe and has a positive effect on children and young adults with juvenile idiopathic arthritis (JIA). JIA is an inflammatory autoimmune disease that can cause severe impairment and disability. JIA can cause bone loss and decreased muscle strength. The medications used to treat JIA can also have negative effects on growth and development, strength, and ability to function. RE is performing movements in a slow and controlled fashion (i.e., no speeding up or using force in the lifting and lowering of the weight) to lessen force on the joints and tissues. This study will be using Ren-Ex exercise equipment to perform RE. Currently the American College of Rheumatology recommends exercise for patients with arthritis. This exercise includes range of motion exercise to protect joint mobility as well as low resistance and aerobic exercise (AE) to protect muscle mass, bone health, and fitness. However, a recent study showed no major differences in functionality or quality of life between patients who performed AE and those who did not perform AE. There is a need for more data on the impact of RE on children with JIA. Children and young adults aged 10 to 21 with juvenile idiopathic arthritis may join.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

May 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 24, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

3.3 years

First QC Date

May 1, 2015

Last Update Submit

April 3, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Total Body Dual-Emission X-ray Absorptiometry (DEXA) Scan

    Total and lean body mass and fat mass will be determined

    Baseline and 12 weeks

  • Change in BMI

    Baseline and 12 weeks

  • Change in Lower and upper extremity strength testing

    Isokinetic strength testing with a Biodex dynamometer to measure peak torque

    Baseline and 12 weeks

Secondary Outcomes (4)

  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    Baseline and 12 weeks

  • Change in Erythrocyte sedimentation rate (ESR)

    Baseline and 12 weeks

  • Change in Quality of Life

    Baseline and 12 weeks

  • Change in C-reactive protein (CRP)

    Baseline and 12 weeks

Study Arms (2)

Resistance Exercise (RE)

EXPERIMENTAL

Those assigned to RE will complete baseline and post-testing assessments and participate in 12 weeks of individually-supervised resistance exercise, which will take place in the exercise facility on the Johns Hopkins Bayview Medical Center Campus. Exercises will be performed on Ren-Ex Machines. This equipment is suitable for the proposed study because it provides ultra-low friction movement which creates a personalized resistance profile, which minimizes force on joints and thereby reduces the risk of joint trauma and injury.

Other: Ren-Ex MachineOther: Dual-Emission X-ray Absorptiometry (DEXA) scanOther: Biodex dynamometerOther: Sub-maximal testOther: Quality of life questionnaires

Control Group (CG)

OTHER

Those assigned to the CG will complete baseline and post-testing assessments and will also be given JIA educational materials, including physical activity and exercise recommendations from the American Academy of Pediatrics (AAP) Council on Sports Medicine and Fitness (COSMF).

Other: Dual-Emission X-ray Absorptiometry (DEXA) scanOther: Biodex dynamometerOther: Sub-maximal testOther: Quality of life questionnaires

Interventions

The exercise is performed once per week with individualized instruction using moderate resistance on Ren-Ex Machines, ultra-low-friction equipment to minimize force on joints.

Resistance Exercise (RE)

To study body composition

Control Group (CG)Resistance Exercise (RE)

To study muscle strength

Also known as: Isokinetic strength testing
Control Group (CG)Resistance Exercise (RE)

To study lung capacity, a sub-maximal (limited exercise) test on a stationary bicycle is performed.

Control Group (CG)Resistance Exercise (RE)
Control Group (CG)Resistance Exercise (RE)

Eligibility Criteria

Age10 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • American College of Rheumatology criteria for polyarticular JIA
  • Stable medical therapy

You may not qualify if:

  • Non-English speaking
  • Pregnancy
  • Currently breast feeding
  • Cognitive impairment as determined by PI (patient is not responsible for making their own health care decisions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Arthritis, Juvenile

Interventions

Absorptiometry, Photon

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

RadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Sangeeta Sule, M.D., Ph.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Control and participant groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2015

First Posted

June 24, 2015

Study Start

July 1, 2012

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

April 5, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations